Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Heres what it means for Medicaid enrollees: Medicaid access through the BALANCE Model could begin as early as May 2026 States must opt in voluntarily its not automatic Participating states receive federally negotiated prices from Eli Lilly (Zepbound, Mounjaro) and Novo Nordisk (Wegovy, Ozempic) Wegovy and Zepbound starting doses would cost the program $350/month (reduced from over $1,000) Patients in participating states would pay $50/month for covered GLP-1s Prior authorization and qualifying criteria will still apply This is the biggest potential expansion of GLP-1 access for Medicaid enrollees in history but it depends on your state deciding to participate
doi: 10.1111/acel.12932 65 ButterfieldDAHalliwellB
Article 6 mins Succession Starts at Onboarding: Lessons From Law Firms Businesses that rely on client relationships face challenges in succession planning as key employees retire or leave the firm
Fact : Actually, GLP-1 weight-loss drugs take a completely different approach than diet pills
In this article, "GLP-1 patch" refers to a marketing label used online-not an FDA-recognized class of GLP-1 medication
US$ 29.16
US$ 21.57
US$ 26.16
US$ 20.85
US$ 26.30
